Literature DB >> 6733973

Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases.

H M Jansen, A J Schutte, J D Elema, M V Giessen, R P Reig, M A Leeuwen, H J Sluiter, T H The.   

Abstract

Evidence is accumulating that the lung injury in collagen vascular diseases (CVD) is triggered by immune complexes (IC). These reactions are neutrophil- and complement-dependent. The direct, in vivo phagocytosis of IC by bronchoalveolar lavage polymorphonuclear leucocytes (BAL-PMN), was studied in 15 patients with CVD and chronic interstitial pulmonary disorders. A control group (NC) consisted of nine healthy, non-smoking volunteers. Concentrations of soluble IC were measured using a solid phase Clq ELISA assay, and an indirect, in vitro phagocytosis assay performed using healthy donor PMN. Local Ig and C3 concentrations were determined using laser nephelometry and Mancini techniques, respectively. In the patient group the total cell counts/ml recovered lavage fluid and the proportions of BAL-PMN were significantly increased (P less than 0.05 and P less than 0.001, respectively). The influxed PMN showed high scores of direct IC phagocytosis. Soluble IC concentrations were significantly increased compared with controls (all comparisons P less than 0.01), and in the BAL relatively higher than in the serum of the same patients. Concomitantly high local IgG concentrations were observed. Corticosteroid treatment gave rise to significantly decreased total cell counts (P less than 0.05), and proportions of BAL-PMN (P less than 0.001), a decrease in the in vivo IC phagocytosis (P less than 0.05), in the indirect, in vitro IC phagocytosis, in the Clq ELISA and in the local IgG concentrations (all comparisons P less than 0.001). We concluded that locally formed IC may induce an inflammatory response in the lungs of patients with CVD.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733973      PMCID: PMC1536245     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma.

Authors:  H M Jansen; T H The; G C de Gast; H A Huiges; M T Esselink; A M van der Wal; N G Orie
Journal:  Thorax       Date:  1977-12       Impact factor: 9.139

2.  Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage.

Authors:  H Y Reynolds; H H Newball
Journal:  J Lab Clin Med       Date:  1974-10

3.  Immunofluorescent and immunologic studies of rheumatoid lung.

Authors:  R J DeHoratius; J L Abruzzo; R C Williams
Journal:  Arch Intern Med       Date:  1972-03

4.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  H Y Reynolds; J D Fulmer; J A Kazmierowski; W C Roberts; M M Frank; R G Crystal
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

5.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

6.  Neutrophil receptors for IgG and complement: their roles in the attachment and ingestion phases of phagocytosis.

Authors:  D J Scribner; D Fahrney
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

7.  Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique.

Authors:  L A Aarden; E R de Groot; T E Feltkamp
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

8.  Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  R Hällgren; L Håkansson; P Venge
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

9.  Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone.

Authors:  W T Butler; R D Rossen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

10.  Immune complexes in peripheral blood polymorphonuclear leucocytes of malignant melanoma patients.

Authors:  T H The; M van der Giessen; H A Huiges; H Schraffordt Koops; I van Wingerden
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

View more
  10 in total

1.  Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.

Authors:  Hongmei Gu; Elizabeth A Mickler; Oscar W Cummings; George E Sandusky; Daniel J Weber; Adam Gracon; Trent Woodruff; David S Wilkes; Ragini Vittal
Journal:  FASEB J       Date:  2014-06-23       Impact factor: 5.191

2.  Immunoglobulin classes in local immune complexes recovered by bronchoalveolar lavage in collagen vascular diseases.

Authors:  H M Jansen; A J Schutte; M van der Giessen; T H The
Journal:  Lung       Date:  1984       Impact factor: 2.584

Review 3.  Complement system in lung disease.

Authors:  Pankita H Pandya; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2014-10       Impact factor: 6.914

4.  The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.

Authors:  Tsukasa Okamoto; Susan K Mathai; Corinne E Hennessy; Laura A Hancock; Avram D Walts; Adrianne L Stefanski; Kevin K Brown; David A Lynch; Gregory P Cosgrove; Steve D Groshong; Carlyne D Cool; Marvin I Schwarz; Nirmal K Banda; Joshua M Thurman; Ivana V Yang; V Michael Holers; David A Schwartz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-22       Impact factor: 5.464

5.  Expression of the CD11/CD18 cell surface adhesion glycoprotein family and MHC class II antigen on blood monocytes and alveolar macrophages in interstitial lung diseases.

Authors:  H C Hoogsteden; P T van Hal; J M Wijkhuijs; W Hop; C Hilvering
Journal:  Lung       Date:  1992       Impact factor: 2.584

6.  Potential Mechanisms Underlying TGF-β-mediated Complement Activation in Lung Fibrosis.

Authors:  Amanda J Fisher; Ellyse Cipolla; Ananya Varre; Hongmei Gu; Elizabeth A Mickler; Ragini Vittal
Journal:  Cell Mol Med Open Access       Date:  2017-11-22

7.  Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases.

Authors:  S Lakhanpal; J T Lie; D L Conn; W J Martin
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

8.  Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease.

Authors:  Van C Willis; M Kristen Demoruelle; Lezlie A Derber; Catherine J Chartier-Logan; Mark C Parish; Isabel F Pedraza; Michael H Weisman; Jill M Norris; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheum       Date:  2013-10

9.  Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies.

Authors:  T G Kimman; F Westenbrink; B E Schreuder; P J Straver
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

10.  Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways.

Authors:  Mayank Saraswat; Sakari Joenväärä; Tiialotta Tohmola; Eva Sutinen; Ville Vartiainen; Katri Koli; Marjukka Myllärniemi; Risto Renkonen
Journal:  Sci Rep       Date:  2020-05-08       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.